These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4851104)

  • 1. Comparison among four vehicles and four routes for administering delta9-tetrahydrocannabinol.
    Sofia RD; Kubena RK; Barry H
    J Pharm Sci; 1974 Jun; 63(6):939-41. PubMed ID: 4851104
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of four vehicles for intraperitoneal administration of -tetrahydrocannabinol.
    Sofia RD; Kubena RK; Barry H
    J Pharm Pharmacol; 1971 Nov; 23(11):889-91. PubMed ID: 4400204
    [No Abstract]   [Full Text] [Related]  

  • 3. Vehicle and route of administration as parameters affecting operant behavioral effects of 9 -tetrahydrocannabinol.
    Borgen LA; Davis WM
    J Pharm Sci; 1973 Mar; 62(3):479-80. PubMed ID: 4691712
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of delta9-tetrahydrocannabinol on social behaviour in mice: comparison between two vehicles.
    Dorr M; Steinberg H
    Psychopharmacology (Berl); 1976 May; 47(1):87-91. PubMed ID: 986665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol.
    Perez-Reyes M; Timmons MC; Lipton MA; Davis KH; Wall ME
    Science; 1972 Aug; 177(4049):633-5. PubMed ID: 4558903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1973; 14(3):353-7. PubMed ID: 4698563
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation of 9-tetrahydrocannabinol for intravenous injection.
    Olsen JL; Makhani M; Davis KH; Wall ME
    J Pharm Pharmacol; 1973 Apr; 25(4):344. PubMed ID: 4146693
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution studies of (14C)delta-9-tetrahydrocannabinol in mice: effect of vehicle, route of administration, and duration of treatment.
    Mantilla-Plata B; Harbison RD
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):292-300. PubMed ID: 1209626
    [No Abstract]   [Full Text] [Related]  

  • 9. An intravenous formulation of 9-tetrahydrocannabinol using a non-ionic surfactant.
    Cradock JC; Davignon JP; Litterst CL; Guarino AM
    J Pharm Pharmacol; 1973 Apr; 25(4):345. PubMed ID: 4146694
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticonvulsant activity of delta-8- and delta-9-tetrahydrocannabinol in rats.
    McCaughran JA; Corcoran ME; Wada JA
    Pharmacol Biochem Behav; 1974; 2(2):227-33. PubMed ID: 4829599
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Perez-Reyes M; Timmons MC; Davis KH; Wall EM
    Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242
    [No Abstract]   [Full Text] [Related]  

  • 12. Shock-elicited fighting and delta-9-tetrahydrocannabinol.
    Manning FJ; Elsmore TF
    Psychopharmacologia; 1972; 25(3):218-28. PubMed ID: 5065158
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of delta9-tetrahydrocannabinol on plasma concentrations of non-esterified fatty acids in the mouse.
    Malor R; Chesher GB; Jackson DM
    J Pharm Pharmacol; 1976 Aug; 28(8):652-4. PubMed ID: 11320
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term use of marihuana and the development of tolerance or sensitivity to delta9 tetrahydrocannabinol.
    Perez-Reyes M; Timmons MC; Wall ME
    Arch Gen Psychiatry; 1974 Jul; 31(1):89-91. PubMed ID: 4835989
    [No Abstract]   [Full Text] [Related]  

  • 15. An inhalation aerosol of delta9-tetrahydrocannabinol.
    Olsen JL; Lodge JW; Shapiro BJ; Tashkin DP
    J Pharm Pharmacol; 1976 Jan; 28(1):86. PubMed ID: 6665
    [No Abstract]   [Full Text] [Related]  

  • 16. The anticonvulsant activity of cannabidiol and cannabinol.
    Karler R; Cely W; Turkanis SA
    Life Sci; 1973 Dec; 13(11):1527-31. PubMed ID: 4768980
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of teratological effects of intravenous, subcutaneous, and intragastric administration of delta9-tetrahydrocannabinol in mice.
    Joneja MG
    Toxicol Appl Pharmacol; 1976 Apr; 36(1):151-62. PubMed ID: 1273835
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
    Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
    Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the effects of 9 -tetrahydrocannabinol by phenobarbital pretreatment in mice.
    Fujimoto JM
    Toxicol Appl Pharmacol; 1972 Dec; 23(4):623-34. PubMed ID: 4644697
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticonvulsant activity of delta9-tetrahydrocannabinol compared with three other drugs.
    Sofia RD; Solomon TA; Barry H
    Eur J Pharmacol; 1976 Jan; 35(1):7-16. PubMed ID: 1253828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.